Search Results - "Di Gennaro, Stefania S"
-
1
Efavirenz is a substrate and in turn modulates the expression of the efflux transporter ABCG2/BCRP in the gastrointestinal tract of the rat
Published in Biochemical pharmacology (01-11-2011)“…The oral bioavailability of the antiretroviral efavirenz (EFV) undergoes high inter and intra-individual variability, this fact supporting its therapeutic drug…”
Get full text
Journal Article -
2
Tetronic® 904-containing polymeric micelles overcome the overexpression of ABCG2 in the blood-brain barrier of rats and boost the penetration of the antiretroviral efavirenz into the CNS
Published in Nanomedicine (London, England) (01-08-2015)“…To assess the involvement of ABCG2 in the pharmacokinetics of efavirenz in the blood-brain barrier (BBB) and investigate a nanotechnology strategy to overcome…”
Get full text
Journal Article -
3
Tetronic registered 904-containing polymeric micelles overcome the overexpression of ABCG2 in the blood-brain barrier of rats and boost the penetration of the antiretroviral efavirenz into the CNS
Published in Nanomedicine (London, England) (01-08-2015)“…Aim: To assess the involvement of ABCG2 in the pharmacokinetics of efavirenz in the blood-brain barrier (BBB) and investigate a nanotechnology strategy to…”
Get full text
Journal Article -
4
Tetronic.sup.[R] 904-containing polymeric micelles overcome the overexpression of ABCG2 in the blood-brain barrier of rats and boost the penetration of the antiretroviral efavirenz into the CNS
Published in Nanomedicine (London, England) (01-08-2015)“…Aim: To assess the involvement of ABCG2 in the pharmacokinetics of efavirenz in the blood-brain barrier (BBB) and investigate a nanotechnology strategy to…”
Get full text
Journal Article -
5
Tetronic
Published in Nanomedicine (London, England) (01-08-2015)“…To assess the involvement of ABCG2 in the pharmacokinetics of efavirenz in the blood-brain barrier (BBB) and investigate a nanotechnology strategy to overcome…”
Get full text
Journal Article